Published 2 months ago • loading... • Updated 2 months ago
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
Summary by The Norfolk Daily News
3 Articles
3 Articles
+2 Reposted by 2 other sources
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
Randomized Phase 2 study in front-line setting progressing well, with nine sites actively recruiting and patient
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium





